Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 270 results for "Zohydro"

Hydrocodone: Rescheduled, Repositioned & Reinvented
Securities Technology Monitor

Zohydro ER Deemed Safe, Effective as Long-Term Chronic Pain Tr...

A late-stage trial of extended-release hydrocodone bitartrate (Zohydro ER) pointed to a generally safe and well-tolerated response among patients with chronic pain for up to 1 year, according to Zogenix, Inc. The phase 3 study found Zohydro ER's ... Pharmacy Times, 2 weeks ago

5 images for Zohydro

Risk & Insurance, 2 months ago
Risk & Insurance, 2 months ago
Risk & Insurance, 2 months ago
Laboratory Equipment, 2 months ago
Boston Herald, 2 months ago
SPi World News

Results of Long-Term, Open-Label Study Published in the Journal of Pain Research Demonstrate the Safety, Tolerability and Effectiveness of Zohydro(R) ER

The safety and tolerability profile of Zohydro ER observed in this study was consistent with the Phase 3 pivotal efficacy study of Zohydro ER and is comparable with other opioid analgesics. The most common adverse events (AEs) observed during the ...
 Morningstar.com2 weeks ago Zogenix, Inc. Release: Results Of Long-Term, Open-Label Study Published In The Demonstrate The Safety, Tolerability And Effectiveness Of Zohydro ER  BioSpace2 weeks ago ZOGENIX : Results of Long-Term, Open-Label Study Published in the Journal of Pain Research Demonstrate the Safety, Tolerability and Effectiveness of Zohydro(R) ER  4 Traders2 weeks ago Zogenix, Inc. And Purdue Pharma L.P. Exchange Waivers Of Regulatory Exclusivity For Extended-Release Hydrocodone Products  BioSpace1 month ago

Reports Outline FDA Actions Findings from Harvard University [Zohydro ? Approval by Food and Drug Administration: Controversial or Frightening?]

By a News Reporter-Staff News Editor at Biotech Week Investigators publish new report on FDA Actions. According to news reporting out of Boston, Massachusetts, by NewsRx editors, research stated, "The actions and regulations of the Food and Drug ...
 Pharmacy Choice1 week ago

FDA approves Purdue's abuse-resistant Hysingla, a hydrocodone pill aimed at knocking off Zohydro

The FDA has faced a firestorm of criticism since approving Zogenix's ($ZGNX) superstrength painkiller Zohydro last year, drawing outcry from lawmakers and industry groups concerned with the drug's all-hydrocodone formula with no features to deter ...
 FiercePharma1 month ago Purdue wins a pain pill approval with Zohydro in its crosshairs  FierceBiotech1 month ago FDA approves abuse-resistant hydrocodone painkiller, offering alternative to Zohydro  Yahoo! Canada1 month ago Purdue Pharma Wins U.S. Approval for Abuse-Deterrent Painkiller  Washington Post1 month ago

2015 Federal Funding Law is a Win for Kentucky

U.S. Rep. Harold "Hal" Rogers (KY-05) praised members of the U.S. Congress for passing the consolidated federal funding bill for fiscal year 2015, to avoid a government shutdown, rein in government overreach, and fund most government agencies ...
 Congressman Hal Rogers3 days ago

FDA approves Hysingla with abuse-deterrent properties

FDA announced in November 2014 the approval of an extended-release, once-daily hydrocodone product (Hysingla ER—Purdue Pharma) with abuse-deterrent properties. The product is the fourth recognized by FDA as having tamper-resistant technology ...
 Pharmacist.com5 days ago FDA Okays Abuse-Deterrent Hydrocodone  MedPage Today1 month ago FDA approves Purdue's opioid analgesic Hysingla ER  Pharma Letter1 month ago FDA Clears Hydrocodone With Abuse-Deterrent Properties  American Journal of Public Health1 month ago

Doctors, Optometrists Battle Over Right to Write Hydrocodone Prescriptions

Some eye conditions -- from serious infections to scrapes to the cornea -- result in agonizing pain, and can send New Jerseyans on a trip to their optometrist. Optometrists evaluate the condition and until recently were able to prescribe ...
 NJ Spotlight1 week ago
Pharma Letter

FDA Focus: Life-threatening disease and the benefit-risk of treatment options

In the fifth of a monthly FDA-focused blog published exclusively by The Pharma Letter, Dr Nicola Davies looks at how the FDA weighs up the risk versus the benefits of new drugs for terminally ill patients. It is painful and traumatic for a ...
 Pharma Letter1 week ago

Long-term painkiller use on the rise, with more patients taking dangerous combos

Amid growing controversy over prescription painkillers, a new study shows that patients who are prescribed opioids continue to use them over a long period of time, indicating potential abuse. The report could add fuel to the fire as lawmakers and ...
 FiercePharma1 week ago Prescription narcotics can aid surgery and cancer patients  Washington Post1 month ago Prescription narcotics are potent painkillers, but they can be deadly  Washington Post1 month ago
Boston Globe

Pain experts weigh in on opioid debate

Legitimate patients having harder time with prescriptions I have my own opinions regarding the topic: "Has health care improved with reclassification of hydrocodone?" (The Argument, Nov. 30) But one theme that has been consistent among mainstream ...
 Boston Globe2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less